| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/20/2002 | US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/20/2002 | US20020076754 Adeno-associated viral particle; for use in the generation of an expression vector which can carry larger nucleotide sequences seqments; tool for gene transfer |
| 06/20/2002 | US20020076753 31939, a novel human leucine-rich repeat family member and uses thereof |
| 06/20/2002 | US20020076752 33395, a novel human leucine-rich repeat family member and uses thereof |
| 06/20/2002 | US20020076750 Peptide for use as tools in human therapeutics and diagnostics |
| 06/20/2002 | US20020076749 Peptide; for use as tools in human diagnostics and therapeutics |
| 06/20/2002 | US20020076748 Nucleotide sequences coding animal cell growth regulator; for us ein the prevent defective cell proliferation; for use as a wound healing agent |
| 06/20/2002 | US20020076746 Macrophage inflammatory protein-4 (mip-4) polynucleotides |
| 06/20/2002 | US20020076745 Human g-protein chemokine receptor hdgnr10 (ccr5 receptor) |
| 06/20/2002 | US20020076737 Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 06/20/2002 | US20020076736 Methods of affecting laminin 5 processing |
| 06/20/2002 | US20020076725 Human t cell clone specific for rheumatoid arthritis |
| 06/20/2002 | US20020076721 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 06/20/2002 | US20020076719 Nucleotide sequences coding veterbrate telomere binding protein for use in the treatment of cancer and aging |
| 06/20/2002 | US20020076717 Method for detecting nucleic acids |
| 06/20/2002 | US20020076713 Mutant Plk protein and gene encoding the same |
| 06/20/2002 | US20020076711 Generating transcriptional control proteins; obtain nucleotide sequences, screen for reguatory sequences, generate transcription control protein, |
| 06/20/2002 | US20020076710 Detection and treatment of breast disease |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076700 Nucleotide sequences coding secreted polypeptide; for use in treatment of cancer, autoimmune and skin disorders, allergies, infection, inflammation, arthritis, hematopoietic, atherosclerosis, restenosis and nervous system disorders |
| 06/20/2002 | US20020076695 Methods for treating prostate cancer |
| 06/20/2002 | US20020076693 Novel cell surface receptor for HIV retroviruses, therapeutic and diagnostic uses |
| 06/20/2002 | US20020076691 Ribonucleic acid microorganism; for use in diangnosis and detection of viral diseases |
| 06/20/2002 | US20020076453 Angiotensin I-converting enzyme inhibitory substance |
| 06/20/2002 | US20020076419 Ligands added to adenovirus fiber |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | US20020076415 Hepatitis C virus gene products |
| 06/20/2002 | US20020076414 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/20/2002 | US20020076412 Administering polypeptides derived from human myelin basic protein; for treatment of autoimmune diseases, multiple sclerosis |
| 06/20/2002 | US20020076407 Method for selectively stimulating proliferation of t cells |
| 06/20/2002 | US20020076405 Antigenized antibody vaccine created from the grafting of peptide epitopes derived from foot-and-mouth disease virus into swine antibody complementarity determining region loops |
| 06/20/2002 | US20020076403 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/20/2002 | US20020076401 Protection from stresses such as hypothermia, ischemia, oxidative stress, and hypoxia by inducing expression of heat shock proteins such as Hsp70 and Hsp27 on-demand in living cells |
| 06/20/2002 | US20020076395 Modified adipose tissue and related implants and methods |
| 06/20/2002 | US20020076392 Non-antibody immunomodulatory molecules such as cytokines expressed as membrane-bound fusion proteins; vaccines; immunotherapy |
| 06/20/2002 | US20020076378 Radically asymmetric dendrimeric polymer (polylactam) backbone linked to at least one reporter moiety; contrast agents which contain large amounts of metal per molecule |
| 06/20/2002 | DE10064906A1 New nucleic acid encoding soluble cytokine receptor, useful for diagnosis and treatment of e.g. immune disease, also related protein and antibodies |
| 06/20/2002 | DE10061525A1 New tetradecapeptides, containing alpha-aminoisobutyric acid residues and a terminal leucinol residue, useful for forming central nervous system-penetrating lipophilic conjugates of drugs, e.g. antibiotics |
| 06/20/2002 | DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants |
| 06/20/2002 | CA2446832A1 Method of treating renal injury |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2434915A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | CA2432782A1 Dimeric fluorescent polypeptides |
| 06/20/2002 | CA2432641A1 Method of preparing alpha-1 proteinase inhibitor |
| 06/20/2002 | CA2431800A1 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 06/20/2002 | CA2431173A1 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2430953A1 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430905A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430901A1 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/20/2002 | CA2430899A1 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 06/20/2002 | CA2430896A1 Mhc class i associated peptides for prevention and treatment of tuberculosis |
| 06/20/2002 | CA2430868A1 Assay for paralytic shellfish toxin |
| 06/20/2002 | CA2430736A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430458A1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | CA2430297A1 Interferon-alpha induced gene |
| 06/20/2002 | CA2430249A1 Bacterial host strains |
| 06/20/2002 | CA2429755A1 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/20/2002 | CA2426948A1 Enhancement of freezing tolerance in transgenic plants |
| 06/20/2002 | CA2425513A1 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | CA2365494A1 Lawsonia intracellularis vaccine |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215284A1 Tsg-like gene |
| 06/19/2002 | EP1215283A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214678A1 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 06/19/2002 | EP1214599A2 Screening for alpha2delta-1 subunit binding ligands |
| 06/19/2002 | EP1214598A2 Screening for inhibitors of "paired helical filaments" |
| 06/19/2002 | EP1214454A1 Hepatitis c virus replication inhibitors |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214439A2 Smooth muscle cell promoter and uses thereof |
| 06/19/2002 | EP1214436A2 Wheat dp proteins and uses thereof |
| 06/19/2002 | EP1214435A2 Seed-preferred promoter from maize |
| 06/19/2002 | EP1214433A1 Methods and means for modification of plant flowering characteristics |
| 06/19/2002 | EP1214429A1 Modulation of ige receptor cell surface expression |
| 06/19/2002 | EP1214417A2 Nucleic acids and proteins from group b streptococcus |
| 06/19/2002 | EP1214414A2 Rip-3-like death-associated kinase |
| 06/19/2002 | EP1214413A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 06/19/2002 | EP1214412A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 06/19/2002 | EP1214411A2 Flint analog compounds and formulations thereof |
| 06/19/2002 | EP1214410A1 Chimaeric plant viruses with mucin peptides |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214402A2 Plant regulatory sequences for selective control of gene expression |
| 06/19/2002 | EP1214399A1 High level cytokine production with enhanced cell viability |
| 06/19/2002 | EP1214351A2 Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 06/19/2002 | EP1214350A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 06/19/2002 | EP1214349A2 Secreted soluble alpha2delta-2, alpha2delta-3 or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 06/19/2002 | EP1214348A2 Parathyroid hormone analogues for the treatment of osteoporosis |
| 06/19/2002 | EP1214346A1 A novel angiogenesis inhibitor |
| 06/19/2002 | EP1214343A2 T2r taste receptor family |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214341A1 Dendritic cell membrane protein fire |
| 06/19/2002 | EP1214340A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/19/2002 | EP1214339A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214336A1 Synthesis of template-fixed beta-hairpin loop mimetics |